These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15265464)

  • 1. Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes.
    Caballero AE
    Curr Diab Rep; 2004 Aug; 4(4):237-46. PubMed ID: 15265464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: the early start of a dangerous situation.
    Caballero AE
    Arch Med Res; 2005; 36(3):241-9. PubMed ID: 15925014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease.
    Caballero AE
    Obes Res; 2003 Nov; 11(11):1278-89. PubMed ID: 14627747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of endothelial dysfunction and low-grade inflammation are associated in the offspring of type 2 diabetic subjects.
    Ruotsalainen E; Vauhkonen I; Salmenniemi U; Pihlajamäki J; Punnonen K; Kainulainen S; Jalkanen S; Salmi M; Laakso M
    Atherosclerosis; 2008 Mar; 197(1):271-7. PubMed ID: 17560580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction, obesity and insulin resistance.
    Prieto D; Contreras C; Sánchez A
    Curr Vasc Pharmacol; 2014 May; 12(3):412-26. PubMed ID: 24846231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E; DeFronzo RA
    Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
    Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
    Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of garlic extract upon endothelial function, vascular inflammation, oxidative stress and insulin resistance in adults with type 2 diabetes at high cardiovascular risk. A pilot double blind randomized placebo controlled trial.
    Atkin M; Laight D; Cummings MH
    J Diabetes Complications; 2016; 30(4):723-7. PubMed ID: 26954484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Stehouwer CD; Schalkwijk CG; Teerlink T; Gram J; Winther K; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 May; 158(5):631-41. PubMed ID: 18426821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endothelial dysfunction in insulin resistance.
    Hsueh WA; Quiñones MJ
    Am J Cardiol; 2003 Aug; 92(4A):10J-17J. PubMed ID: 12957322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
    Lewis GF; Carpentier A; Adeli K; Giacca A
    Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved endothelial function with metformin in type 2 diabetes mellitus.
    Mather KJ; Verma S; Anderson TJ
    J Am Coll Cardiol; 2001 Apr; 37(5):1344-50. PubMed ID: 11300445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential pathogenic inflammatory mechanisms of endothelial dysfunction induced by type 2 diabetes mellitus.
    Kampoli AM; Tousoulis D; Briasoulis A; Latsios G; Papageorgiou N; Stefanadis C
    Curr Pharm Des; 2011 Dec; 17(37):4147-58. PubMed ID: 22204375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players.
    Zimmet P; Boyko EJ; Collier GR; de Courten M
    Ann N Y Acad Sci; 1999 Nov; 892():25-44. PubMed ID: 10842650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifestyle modification and endothelial function in obese subjects.
    Hamdy O
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA.
    Sydow K; Mondon CE; Cooke JP
    Vasc Med; 2005 Jul; 10 Suppl 1():S35-43. PubMed ID: 16444867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
    Meyers MR; Gokce N
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes.
    Mishra M; Kumar H; Bajpai S; Singh RK; Tripathi K
    Diabetes Res Clin Pract; 2011 Nov; 94(2):255-61. PubMed ID: 21855158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study.
    van Sloten TT; Henry RM; Dekker JM; Nijpels G; Unger T; Schram MT; Stehouwer CD
    Hypertension; 2014 Dec; 64(6):1299-305. PubMed ID: 25225211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.